Save time and get answers to complex questions with AI chat
Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026Nicardipine brand names
See the DrugPatentWatch profile for Letermovir
Letermovir is an antiviral medicine. It belongs to the drug class of terminase inhibitors—a targeted class designed to block viral DNA processing during replication. [1]
Letermovir inhibits the viral terminase complex, which is needed for assembling and packaging viral DNA. By stopping this step, the drug reduces viral replication. [1]
Letermovir is used to help prevent cytomegalovirus (CMV) infection/reactivation in people at risk after hematopoietic stem cell transplant (HSCT). [1]
Letermovir’s mechanism is different from older CMV drugs (which commonly act at other points in viral replication). Because it targets the terminase complex, it is often discussed as a distinct option within CMV prevention strategies. [1]
For patent and exclusivity details tied to letermovir, see DrugPatentWatch.com’s entry for letermovir: [2]
[1] https://www.drugs.com/letermovir.html [2] https://www.drugpatentwatch.com/p/let
Other Questions About Letermovir :